cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

May 09, 2025 12:57 PM EDT | Source: cbdMD

Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.

CONFERENCE CALL DETAILS

Thursday, May 15, 2025, 4:20 p.m. Eastern Time
 
USA/Canada:833-821-3524
  
International:647-846-2919
  
Teleconference Replay dial in:
 
USA/Canada:855-669-9658
  
International:412-317-0088
  
Replay Passcode:7254091
  
Webcast/Webcast Replay link - available through May 15, 2026:

https://www.gowebcasting.com/14065

About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced THC-free1 CBD products and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products and our ATRx brand features functional mushroom products. In addition, we operate Herbal Oasis, a premium, award winning THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, ATRxlabs.com, or Herbaloasis.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251499

info